ELITechGroup receives FDA Emergency Use Authorization for Zika ELITe MGB® Kit U.S. performed using the ELITe InGenius™ instrument

Puteaux, France, December 9th, 2016 – ELITechGroup announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Zika ELITe MGB^® Kit U.S. performed using the ELITe InGenius™ instrument, a fully automated sample-to-result system. This real-time PCR-based test utilizes ELITechGroup Molecular Diagnostics proprietary MGB Technology to target a highly conserved coding region for the qualitative detection of Zika virus RNA in serum or plasma from patients meeting CDC Zika virus clinical criteria and/or CDC Zika virus epidemiological criteria.   To read more >> download the pdf“